Author

Mary-Jane Navarro

University of WashingtonORCID 0000-0001-5716-459XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Alexandra C. WallsiD· 3 shared David VeesleriD· 3 shared Alexandra SchäferiD· 2 shared Amin AddetiaiD· 2 shared Catherine TreicheliD· 2 shared Elizabeth M. LeafiD· 2 shared Jimin LeeiD· 2 shared Marcos C. MirandaiD· 2 shared

Activity by Year

2022-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Alexandra C. WallsORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyScience Translational MedicinePeer-reviewedOct 15, 2025

Computationally designed mRNA-launched protein nanoparticle vaccines

Grace G. Hendricks, Lilit Grigoryan, Mary Jane Navarro…·Neil P. King

This paper develops an mRNA-launched nanoparticle vaccine that combines protein nanoparticle and mRNA vaccine advantages, showing enhanced antibody and T cell responses in mice.

24 citationstop 1%

mousemultiome

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 11, 2025

Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccines

Amin Addetia, Alexandra Schäfer, Kaitlin R. Sprouse…·David Veesler

This paper designs multivalent RBD nanoparticle vaccines that overcome immune imprinting and provide broad protection against SARS-CoV-2 variants and sarbecoviruses.

4 citations

non-human primateproteomics

𝕏 PostBluesky

Synthetic BiologyScience Translational MedicinePeer-reviewedApr 12, 2022

Multivalent designed proteins protect against SARS-CoV-2 variants of concern

Andrew C. Hunt, James Brett Case, Young‐Jun Park…·David A. Baker

The paper designs and characterizes trivalent miniprotein binders that neutralize SARS-CoV-2 variants with low pM IC50 values and provide prophylactic and therapeutic protection in mice.

122 citationstop 1%

humanexperimental assay

𝕏 PostBluesky